...
首页> 外文期刊>Annals of microbiology >In vitro probiotic characterization of high GABA producing strain Lactobacilluas brevis DSM 32386 isolated from traditional “wild” Alpine cheese
【24h】

In vitro probiotic characterization of high GABA producing strain Lactobacilluas brevis DSM 32386 isolated from traditional “wild” Alpine cheese

机译:在<斜视>体外>高GABA生产菌株的益生菌表征<斜杆菌>叶杆菌BREVIS DSM 32386与传统的“野生”高山奶酪

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose γ-Aminobutyric acid (GABA) is recognised as a potential metabolic bioactive food ingredient with increasing evidence of its effects on the gut-brain axis and systemic metabolic health. Different lactic acid bacteria are capable of producing GABA, particularly strains of Lactobacillus brevis . In this study, we characterized a Lb. brevis isolated from traditional alpine cheese ( Lb. brevis DSM 32386) for its ability to accumulate high levels of GABA in the culture medium and for other important probiotic phenotypic traits. Methods In vitro analysis were used to study the Lb. brevis DSM 32386 probiotic traits and the gene expression involved in GABA production Result Lactobacillus brevis DSM 32386 converted monosodium glutamate to GABA more efficiently than the type strain Lb. brevis DSM 20054, resulting in more than 200% of GABA produced. This ability seemed to be related to the higher transcriptional activation of the gene encoding for the glutamate (gad) decarboxylase antiporter ( gadC ) and regulator ( gadR ). Lactobacillus brevis DSM 32386 performed well in vitro under the stress conditions mimicking the gastro-intestinal tract, being resistant to acid pH (pH 2.5) and growing in simulated pancreatic fluid and 0.3% ox-bile. Conclusion These preliminary studies indicate that Lb. brevis DSM 32386 holds promise as a starter for GABA-rich dairy fermented foods and possibly a promising next-generation probiotic microorganism in the context of the gut (microbiota):brain axis.
机译:目的,γ-氨基丁酸(GABA)被认为是潜在的代谢生物活性食品成分,随着其对肠脑轴和全身代谢健康的影响。不同的乳酸菌能够产生GABA,特别是乳酸杆菌的菌株。在这项研究中,我们的表征为LB. BREVIS从传统的高山乳酪(LB.BREVIS DSM 32386)中分离出它在培养基中积累高水平的GABA和其他重要的益生菌表型特征。体外分析的方法用于研究LB. BREVIS DSM 32386益生菌性状和参与GABA生产结果的基因表达乳酸杆菌BREVIS DSM 32386比菌株LB更有效地转化为GABA的谷氨酸至GABA。 BREVIS DSM 20054,导致200%以上的GABA生产。这种能力似乎与谷氨酸(GAD)脱羧酶抗纤维(GADC)和调节剂(GADR)的较高转录激活相关。在模仿胃肠道的应力条件下,乳酸杆菌在体外表现良好,耐酸pH(pH2.5),并且在模拟的胰液中生长和0.3%的牛胆汁。结论这些初步研究表明LB. BREVIS DSM 32386将承诺作为GABA的乳制品发酵食品的起动器,并且可能在肠道(微生物群)的背景下有前一代益生菌微生物:脑轴。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号